Advertisement

---

QUESTCOR PHARMACEUTICALS, INC.

Questcor Pharmaceuticals Acquires Rights to Synacthen®

[2013-06-11] - - Expands Questcor's Presence in Inflammatory and Autoimmune Disorders -
- Provides Foundation for Next Generation Melanocortin Receptor Agonist Therapeutics -
- Initiates Global Footprint, Diversifies Business, Enhances Long-term Growth Prospects -


Questcor Adds Angus C. Russell to Board of Directors

[2013-06-10] -


Questcor Pharmaceuticals Announces Quarterly Dividend

[2013-05-29] -


Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference

[2013-05-08] -


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers